52 related articles for article (PubMed ID: 26349245)
21. SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
Suzuki Y; Haraguchi N; Takahashi H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Ishii H; Doki Y; Mori M; Yamamoto H
Int J Oncol; 2013 Jan; 42(1):161-7. PubMed ID: 23175153
[TBL] [Abstract][Full Text] [Related]
22. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
[TBL] [Abstract][Full Text] [Related]
23. Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.
Toden S; Ravindranathan P; Gu J; Cardenas J; Yuchang M; Goel A
Sci Rep; 2018 Feb; 8(1):3335. PubMed ID: 29463813
[TBL] [Abstract][Full Text] [Related]
24. Enrichment of Oct3/4-positive cells from a human bronchial epithelial cell line.
Li X; Jia L; Jia X; Shi M; Li X; Ye X; Wang R; Xiong Y; Wang E; Li F
APMIS; 2013 Jul; 121(7):612-25. PubMed ID: 23216104
[TBL] [Abstract][Full Text] [Related]
25. Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance.
Wiener Z; Högström J; Hyvönen V; Band AM; Kallio P; Holopainen T; Dufva O; Haglund C; Kruuna O; Oliver G; Ben-Neriah Y; Alitalo K
Cell Rep; 2014 Sep; 8(6):1943-1956. PubMed ID: 25242330
[TBL] [Abstract][Full Text] [Related]
26. Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.
Qureshi-Baig K; Ullmann P; Haan S; Letellier E
Mol Cancer; 2017 Feb; 16(1):40. PubMed ID: 28209178
[TBL] [Abstract][Full Text] [Related]
27. Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function.
Storm EE; Durinck S; de Sousa e Melo F; Tremayne J; Kljavin N; Tan C; Ye X; Chiu C; Pham T; Hongo JA; Bainbridge T; Firestein R; Blackwood E; Metcalfe C; Stawiski EW; Yauch RL; Wu Y; de Sauvage FJ
Nature; 2016 Jan; 529(7584):97-100. PubMed ID: 26700806
[TBL] [Abstract][Full Text] [Related]
28. Targeting a murky cancer reservoir: more researchers set their sights on cancer stem cells.
Nelson B
Cancer Cytopathol; 2013 Feb; 121(2):55-6. PubMed ID: 23408695
[No Abstract] [Full Text] [Related]
29. A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics.
Weekes SL; Barker B; Bober S; Cisneros K; Cline J; Thompson A; Hlatky L; Hahnfeldt P; Enderling H
Bull Math Biol; 2014 Jul; 76(7):1762-82. PubMed ID: 24840956
[TBL] [Abstract][Full Text] [Related]
30. The cancer stem cell: premises, promises and challenges.
Clevers H
Nat Med; 2011 Mar; 17(3):313-9. PubMed ID: 21386835
[TBL] [Abstract][Full Text] [Related]
31. Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells.
Chang CJ; Chien Y; Lu KH; Chang SC; Chou YC; Huang CS; Chang CH; Chen KH; Chang YL; Tseng LM; Song WS; Wang JJ; Lin JK; Huang PI; Lan YT
Biochem Biophys Res Commun; 2011 Nov; 415(2):245-51. PubMed ID: 22037460
[TBL] [Abstract][Full Text] [Related]
32. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer stem cells.
Yeung TM; Mortensen NJ
Dis Colon Rectum; 2009 Oct; 52(10):1788-96. PubMed ID: 19966616
[TBL] [Abstract][Full Text] [Related]
34. [SUPPRESSION OF TUMOR GROWTH AFTER XENOGRAFTING OF HUMAN COLORECTAL CARCINOMA CELLS].
Davydov-Sinitsyn AP; Bazhenova OV; Liskovykh MA; Ponomartsev SV; Rykov IV; Koshkin SA; Orlova RV; Tomilin AN; Tolkunova EN
Tsitologiia; 2015; 57(4):278-85. PubMed ID: 26349245
[TBL] [Abstract][Full Text] [Related]
35. [In vitro derivation and characterization of a colorectal cancer stem cell subpopulation].
Davydov-Sinitsyn AP; Bazhenova OV; Liskovykh MA; Chechik LL; Ponomartsev CV; Tomilin AN; Tolkunova EN
Tsitologiia; 2013; 55(5):318-23. PubMed ID: 24592739
[TBL] [Abstract][Full Text] [Related]
36. [A comparative analysis of colorectal carcinoma cell lines that differ in metastatic potential].
Davydov-Sinitsyn AP; Bazhenova OV; Liskovykh MA; Ponomartsev SV; Chechik LL; Tomilin AN; Tolkunova EN
Tsitologiia; 2013; 55(6):379-87. PubMed ID: 25509104
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
